Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856

Schizophrenia is a complex psychopathology whose treatment is still challenging. Given the limitations of existing antipsychotics, there is urgent need for novel drugs with fewer side effects. SEP-363856 (SEP-856) is a novel psychotropic agent currently under phase III clinical investigation for sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Begni, Veronica, Sanson, Alice, Luoni, Alessia, Sensini, Federica, Grayson, Ben, Munni, Syeda, Neill, Joanna C., Riva, Marco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073823/
https://www.ncbi.nlm.nih.gov/pubmed/33923479
http://dx.doi.org/10.3390/ijms22084119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073823/
https://www.ncbi.nlm.nih.gov/pubmed/33923479
http://dx.doi.org/10.3390/ijms22084119

Ejemplares similares